Global Pharmatech, Inc. (GBLP)
OTCMKTS · Delayed Price · Currency is USD
0.0500
0.00 (0.00%)
Jan 22, 2026, 4:00 PM EST
Global Pharmatech Revenue
Global Pharmatech had revenue of $728.20K in the quarter ending June 30, 2008, with 21.52% growth. This brings the company's revenue in the last twelve months to $3.18M, up 55.57% year-over-year. In the year 2007, Global Pharmatech had annual revenue of $2.82M with 32.43% growth.
Revenue (ttm)
3.18M
Revenue Growth
+55.57%
P/S Ratio
6.53
Revenue / Employee
14.65K
Employees
217
Market Cap
20.76M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2007 | 2.82M | 690.35K | 32.43% |
| Dec 31, 2006 | 2.13M | -956.44K | -31.00% |
| Dec 31, 2005 | 3.09M | 1.53M | 98.32% |
| Dec 31, 2004 | 1.56M | -165.24K | -9.60% |
| Dec 31, 2003 | 1.72M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hanover Foods | 330.81M |
| Elamex SA de CV | 110.74M |
| Integrated BioPharma | 53.43M |
| Starco Brands | 47.15M |
| DAVIDsTEA | 43.33M |
| Limitless X Holdings | 1.13M |
| Glucose Health | 1.11M |
| Next Meats Holdings | 1.05M |